 |
|
|
|
FPG has a strong team focused upon the Biotechnology Sector. Its members, including senior scientists
in New York and London, have extensive hands-on experience of discovery research, clinical
development, intellectual property rights, commercialization and financing activities within the global
biopharmaceutical industry. Within its overall classic focus on Corporate Partnering, Equity Financing,
Acquisition and Divestment transactions, FPG's expertise includes these specialized capabilities:
 | Review and Validation of Client Company and Counterparty Technologies | | Due Diligence Assessment: basic science, clinical development programs, marketing plans and financing | | Preparation and/or review of Business Plans to Support Equity Financing | | Identification of, and Negotiation with, Potential Investors | | Identification of, and Negotiation with, Counterparties for Corporate Partnering | | Identification of, and Negotiation with, Counterparties for Acquisitions, Divestitures and Mergers |
FPG has evolved its Biotechnology franchise with a focus on both innovative therapeutic and diagnostic
companies as well as on Enabling Technology companies active in the following disciplines:
| |
| |
| > Antibodies/Mimetics |
> Drug Delivery |
> Glycomics |
| > BioChips |
> Gene Discovery |
> High Throughput Screening |
| > Bioinformatics |
> Gene Expression |
> Pharmacogenomics |
| > BioMarkers |
> Gene Therapy/Antisense |
> Proteomics |
| > Combinatorial Biology |
> Genetic Technologies |
> RNAi |
| > Combinatorial Chemistry |
> Genomics |
> Secondary Screening |
|
Incremental Services and Smaller Transactions
In order to provide its clients with incremental advisory services, FPG has developed a collaborative
working relationship with bioStrategies Group, a global strategy consulting firm that works with
Life Science companies to commercialize their products and technologies. The firmâs clientele ranges
from some of the leading biopharmaceutical, drug discovery tool, diagnostic and medical device
companies to startups seeking early stage advice. bioStrategies Groupâs approaches blend strong market
research, quantitative methods, strategic frameworks and extensive industry experience to assist its
clients in making key commercialization decisions. Typical strategy engagements involve research pipeline
and product portfolio management, business model definition, product and clinical development strategy,
market research and the related marketing plans for specific products.
For smaller clients or for smaller transactions, FPG has created a stand-alone but affiliated
advisory service, Capel Thompson & Homer, headed by long-term London colleague, Paul Thompson.
This separate firm specializes in European partnering transactions, interim project management, business
development, product disposals/purchases and technology sales/acquisitions.
|
|
| |
 |
|
|
